|
US6914A
(en)
|
|
1849-11-27 |
|
Propeller |
|
US128A
(en)
|
|
1837-02-16 |
|
Holdback for sleds |
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5811523A
(en)
|
1988-11-10 |
1998-09-22 |
Trinchieri; Giorgio |
Antibodies to natural killer stimulatory factor
|
|
EP0368684B2
(en)
|
1988-11-11 |
2004-09-29 |
Medical Research Council |
Cloning immunoglobulin variable domain sequences.
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
WO1991005058A1
(en)
|
1989-10-05 |
1991-04-18 |
Glenn Kawasaki |
Cell-free synthesis and isolation of novel genes and polypeptides
|
|
US5780597A
(en)
|
1989-12-22 |
1998-07-14 |
Hoffmann-La Roche Inc. |
Monoclonal antibodies to cytotoxic lymphocyte maturation factor
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
CA2109602C
(en)
|
1990-07-10 |
2002-10-01 |
Gregory P. Winter |
Methods for producing members of specific binding pairs
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
US7084260B1
(en)
|
1996-10-10 |
2006-08-01 |
Genpharm International, Inc. |
High affinity human antibodies and human antibodies against human antigens
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
DE69133476T2
(de)
|
1990-08-29 |
2006-01-05 |
GenPharm International, Inc., Palo Alto |
Transgene Mäuse fähig zur Produktion heterologer Antikörper
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
|
US5919452A
(en)
|
1991-03-18 |
1999-07-06 |
New York University |
Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
|
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
US5656272A
(en)
|
1991-03-18 |
1997-08-12 |
New York University Medical Center |
Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
|
|
US6284471B1
(en)
|
1991-03-18 |
2001-09-04 |
New York University Medical Center |
Anti-TNFa antibodies and assays employing anti-TNFa antibodies
|
|
US5698195A
(en)
|
1991-03-18 |
1997-12-16 |
New York University Medical Center |
Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies
|
|
CA2108147C
(en)
|
1991-04-10 |
2009-01-06 |
Angray Kang |
Heterodimeric receptor libraries using phagemids
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
EP0605522B1
(en)
|
1991-09-23 |
1999-06-23 |
Medical Research Council |
Methods for the production of humanized antibodies
|
|
GB9122820D0
(en)
|
1991-10-28 |
1991-12-11 |
Wellcome Found |
Stabilised antibodies
|
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
|
JPH07509137A
(ja)
|
1992-07-24 |
1995-10-12 |
セル ジェネシス，インク． |
異種抗体の生産
|
|
US5652138A
(en)
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
|
PT614984E
(pt)
|
1993-03-05 |
2001-12-28 |
Bayer Ag |
Anticorpos humanos anti-tnf
|
|
CA2161351C
(en)
|
1993-04-26 |
2010-12-21 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5464758A
(en)
|
1993-06-14 |
1995-11-07 |
Gossen; Manfred |
Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
|
|
US5654168A
(en)
|
1994-07-01 |
1997-08-05 |
Basf Aktiengesellschaft |
Tetracycline-inducible transcriptional activator and tetracycline-regulated transcription units
|
|
CA2125763C
(en)
|
1993-07-02 |
2007-08-28 |
Maurice Kent Gately |
P40 homodimer of interleukin-12
|
|
EP0638644A1
(en)
|
1993-07-19 |
1995-02-15 |
F. Hoffmann-La Roche Ag |
Receptors of interleukin-12 and antibodies
|
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
|
ZA95960B
(en)
|
1994-03-14 |
1995-10-10 |
Genetics Inst |
Use of interleukin-12 antagonists in the treatment of autoimmune diseases
|
|
US5910486A
(en)
|
1994-09-06 |
1999-06-08 |
Uab Research Foundation |
Methods for modulating protein function in cells using, intracellular antibody homologues
|
|
US5562138A
(en)
*
|
1994-10-13 |
1996-10-08 |
The Longaberger Company |
Bowing press
|
|
ATE390933T1
(de)
|
1995-04-27 |
2008-04-15 |
Amgen Fremont Inc |
Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US5853697A
(en)
|
1995-10-25 |
1998-12-29 |
The United States Of America, As Represented By The Department Of Health & Human Services |
Methods of treating established colitis using antibodies against IL-12
|
|
US6297395B1
(en)
|
1995-11-10 |
2001-10-02 |
The Secretary Of State For Defence In Her Brittanic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland |
Calixarenes and their use for sequestration of metals
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
CN1300173C
(zh)
|
1996-02-09 |
2007-02-14 |
艾博特生物技术有限公司 |
结合人TNFα的人抗体
|
|
AU7257696A
(en)
|
1996-10-11 |
1998-05-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12
|
|
PT936923E
(pt)
|
1996-11-15 |
2004-04-30 |
Kennedy Inst Of Rheumatology |
Supressao de tnfalfa e il-12 em terapia
|
|
DK1500329T3
(da)
|
1996-12-03 |
2012-07-09 |
Amgen Fremont Inc |
Humane antistoffer, der specifikt binder TNF-alfa
|
|
US6054487A
(en)
|
1997-03-18 |
2000-04-25 |
Basf Aktiengesellschaft |
Methods and compositions for modulating responsiveness to corticosteroids
|
|
HUP0104439A3
(en)
|
1997-03-18 |
2002-08-28 |
Basf Ag |
Pharmaceutical compositions for modulating responsiveness to corticosteroids and use thereof
|
|
US6183744B1
(en)
|
1997-03-24 |
2001-02-06 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
CA2297692A1
(en)
|
1997-08-18 |
1999-02-25 |
Innogenetics N.V. |
Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
|
|
EP0969867B1
(en)
|
1997-10-31 |
2004-09-01 |
Wyeth |
Use of anti-il-12 antibodies in transplantation rejection
|
|
KR100764256B1
(ko)
|
1998-01-23 |
2007-10-05 |
에프. 호프만-라 로슈 아게 |
인간 인터루킨-12에 대한 항체
|
|
US20020161199A1
(en)
|
1998-04-08 |
2002-10-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
EP0953639A1
(en)
|
1998-04-30 |
1999-11-03 |
Boehringer Ingelheim International GmbH |
FAPalpha-specific antibody with improved producibility
|
|
EP1137766B1
(en)
|
1998-12-09 |
2005-09-28 |
Protein Design Labs, Inc. |
Use of il-12 antibodies to treat psoriasis
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
US7883704B2
(en)
|
1999-03-25 |
2011-02-08 |
Abbott Gmbh & Co. Kg |
Methods for inhibiting the activity of the P40 subunit of human IL-12
|
|
DK2168984T3
(da)
|
1999-03-25 |
2012-12-10 |
Abbott Gmbh & Co Kg |
Humane antistoffer, som binder humant IL-12, og fremgangsmåder til pro-duktion heraf
|
|
PL202058B1
(pl)
*
|
1999-08-09 |
2009-05-29 |
Merck Patent Gmbh |
Wielofunkcyjne białko fuzyjne cytokin i przeciwciała
|
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
|
KR20030074693A
(ko)
|
2000-12-28 |
2003-09-19 |
알투스 바이올로직스 인코포레이티드 |
전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법
|
|
WO2002098445A1
(fr)
|
2001-05-30 |
2002-12-12 |
Chugai Seiyaku Kabushiki Kaisha |
Preparation de proteines
|
|
WO2002097048A2
(en)
|
2001-05-30 |
2002-12-05 |
Centocor, Inc. |
ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
|
|
WO2003097082A2
(en)
*
|
2002-05-17 |
2003-11-27 |
Protein Design Labs |
Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
|
|
AU2003251906B2
(en)
|
2002-07-12 |
2008-12-04 |
Medarex, Inc. |
Methods and compositions for preventing oxidative degradation of proteins
|
|
US20090280065A1
(en)
|
2006-04-10 |
2009-11-12 |
Willian Mary K |
Uses and Compositions for Treatment of Psoriasis
|
|
US7608260B2
(en)
|
2003-01-06 |
2009-10-27 |
Medimmune, Llc |
Stabilized immunoglobulins
|
|
KR101224235B1
(ko)
|
2003-04-11 |
2013-01-25 |
메디뮨 엘엘씨 |
재조합 ｉｌ９ 항체 및 그의 용도
|
|
EP1623011B1
(en)
|
2003-05-09 |
2013-01-02 |
Janssen Biotech, Inc. |
Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
|
|
JP2007503839A
(ja)
*
|
2003-09-04 |
2007-03-01 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
新規ＵＢＰ８ｒｐポリペプチドおよび乾癬の治療におけるその使用
|
|
JP4219932B2
(ja)
|
2003-10-01 |
2009-02-04 |
協和発酵キリン株式会社 |
抗体の安定化方法及び安定化された溶液状抗体製剤
|
|
CA2550505A1
(en)
|
2003-12-19 |
2005-06-30 |
Protemix Corporation Limited |
Copper antagonist compounds
|
|
SG10201900535UA
(en)
|
2003-12-23 |
2019-02-27 |
Genentech Inc |
Novel anti-il 13 antibodies and uses thereof
|
|
JP2007522157A
(ja)
|
2004-02-12 |
2007-08-09 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
抗ｅｇｆｒ抗体の高濃縮液体製剤
|
|
RU2292215C2
(ru)
*
|
2004-05-21 |
2007-01-27 |
Дмитрий Васильевич Николенко |
Комплекс для лечения псориаза и способ лечения
|
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
|
ZA200700947B
(en)
|
2004-07-23 |
2008-06-25 |
Genentech Inc |
Crystallization of antibodies or fragments thereof
|
|
SG158150A1
(en)
|
2004-12-21 |
2010-01-29 |
Centocor Inc |
Anti-il-12 antibodies, epitopes, compositions, methods and uses
|
|
CA2898009C
(en)
*
|
2005-05-16 |
2018-03-27 |
Rebecca S. Hoffman |
Use of tnfa inhibitor for treatment of erosive polyarthritis
|
|
EP1896073B1
(en)
|
2005-06-30 |
2013-03-06 |
Janssen Biotech, Inc. |
Anti-il-23 antibodies, compositions, methods and uses
|
|
KR20080098504A
(ko)
|
2006-02-03 |
2008-11-10 |
메디뮨 엘엘씨 |
단백질 제제
|
|
EP2636754B1
(en)
|
2006-09-11 |
2015-03-04 |
Celera Corporation |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
|
SG175622A1
(en)
|
2006-10-13 |
2011-11-28 |
Centocor Ortho Biotech Inc |
Enhancement of hybridoma fusion efficiencies through cell synchronization
|
|
KR20150038227A
(ko)
|
2007-01-16 |
2015-04-08 |
애브비 인코포레이티드 |
건선의 치료방법
|
|
RU2476442C2
(ru)
|
2007-03-29 |
2013-02-27 |
Эббот Лэборетриз |
Кристаллические антитела против il-12 человека
|
|
KR20100126515A
(ko)
|
2008-03-18 |
2010-12-01 |
아보트 러보러터리즈 |
건선의 치료방법
|
|
CN104398471A
(zh)
|
2008-11-28 |
2015-03-11 |
Abbvie公司 |
稳定的抗体组合物和用于稳定其的方法
|
|
AU2010291927A1
(en)
|
2009-09-14 |
2012-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Methods for treating psoriasis
|
|
MX2013003920A
(es)
|
2010-10-06 |
2013-06-03 |
Abbvie Inc |
Metodos para el tratamiento de la psoriasis.
|
|
WO2012094623A2
(en)
|
2011-01-07 |
2012-07-12 |
Abbott Laboratories |
Anti-il-12/il-23 antibodies and uses thereof
|
|
WO2012097288A1
(en)
|
2011-01-14 |
2012-07-19 |
Abbott Laboratories |
Human antibodies that bind the p40 subunit of human il-12/il-23 and uses therefor
|